Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy

HIGHLIGHTS

• who: Peter M. Klooster from the Windlesham, Surrey, UK Arthritis Centre Twente, University of Twente have published the research work: Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy, in the Journal: (JOURNAL)
• what: The aim of this study was to, retrospectively, compare the long-term clinical, functional, and cost outcomes for early RA patients who did or did not achieve early remission in a real-world treat-to-target strategy. In this study, costs were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.